149 related articles for article (PubMed ID: 32981900)
41. Cattle mammary bioreactor generated by a novel procedure of transgenic cloning for large-scale production of functional human lactoferrin.
Yang P; Wang J; Gong G; Sun X; Zhang R; Du Z; Liu Y; Li R; Ding F; Tang B; Dai Y; Li N
PLoS One; 2008; 3(10):e3453. PubMed ID: 18941633
[TBL] [Abstract][Full Text] [Related]
42. Effect of Metformin Nanoparticle-Mediated Thioredoxin Interacting Protein Expression on Oxaliplatin-Induced Peripheral Neuralgia.
Liu Y; Zhou G; Xu N
J Nanosci Nanotechnol; 2020 Oct; 20(10):6123-6132. PubMed ID: 32384961
[TBL] [Abstract][Full Text] [Related]
43. The analgesic effect of orexin-A in a murine model of chemotherapy-induced neuropathic pain.
Toyama S; Shimoyama N; Shimoyama M
Neuropeptides; 2017 Feb; 61():95-100. PubMed ID: 28041630
[TBL] [Abstract][Full Text] [Related]
44. Recombinant human lactoferrin carrying humanized glycosylation exhibits antileukemia selective cytotoxicity, microfilament disruption, cell cycle arrest, and apoptosis activities.
Nakamura-Bencomo S; Gutierrez DA; Robles-Escajeda E; Iglesias-Figueroa B; Siqueiros-Cendón TS; Espinoza-Sánchez EA; Arévalo-Gallegos S; Aguilera RJ; Rascón-Cruz Q; Varela-Ramirez A
Invest New Drugs; 2021 Apr; 39(2):400-415. PubMed ID: 33063290
[TBL] [Abstract][Full Text] [Related]
45. Evaluation of the bioactivity of recombinant human lactoferrins toward murine osteoblast-like cells for bone tissue engineering.
Amini AA; Nair LS
Tissue Eng Part A; 2013 May; 19(9-10):1047-55. PubMed ID: 23270517
[TBL] [Abstract][Full Text] [Related]
46. Recombinant human lactoferrin enhances the efficacy of triple therapy in mice infected with Helicobacter pylori.
Yuan Y; Wu Q; Cheng G; Liu X; Liu S; Luo J; Zhang A; Bian L; Chen J; Lv J; Dong X; Yang G; Zhu Y; Ma L
Int J Mol Med; 2015 Aug; 36(2):363-8. PubMed ID: 26080893
[TBL] [Abstract][Full Text] [Related]
47. [Isolation and purification of recombinant human lactoferrin (rhLF) from transgenic rice and its antibacterial activities].
Wu J; Yang L; Liu G; Gong Z; Liu J; Hu Y; Guo Y; Piao J; Shen Z; Yang X
Wei Sheng Yan Jiu; 2013 May; 42(3):399-404. PubMed ID: 23805514
[TBL] [Abstract][Full Text] [Related]
48. The role of N-linked glycosylation in the protection of human and bovine lactoferrin against tryptic proteolysis.
van Veen HA; Geerts ME; van Berkel PH; Nuijens JH
Eur J Biochem; 2004 Feb; 271(4):678-84. PubMed ID: 14764083
[TBL] [Abstract][Full Text] [Related]
49. Role of PAR2 in regulating oxaliplatin-induced neuropathic pain via TRPA1.
Tian L; Fan T; Zhou N; Guo H; Zhang W
Transl Neurosci; 2015; 6(1):111-116. PubMed ID: 28123794
[TBL] [Abstract][Full Text] [Related]
50. Immunomodulatory properties of human recombinant lactoferrin in mice: Implications for therapeutic use in humans.
Artym J; Kocięba M; Zaczyńska E; Adamik B; Kübler A; Zimecki M; Kruzel M
Adv Clin Exp Med; 2018 Mar; 27(3):391-399. PubMed ID: 29533543
[TBL] [Abstract][Full Text] [Related]
51. Curcumin Alleviates Oxaliplatin-Induced Peripheral Neuropathic Pain through Inhibiting Oxidative Stress-Mediated Activation of NF-κB and Mitigating Inflammation.
Zhang X; Guan Z; Wang X; Sun D; Wang D; Li Y; Pei B; Ye M; Xu J; Yue X
Biol Pharm Bull; 2020 Feb; 43(2):348-355. PubMed ID: 31776306
[TBL] [Abstract][Full Text] [Related]
52. Production of recombinant human lactoferrin in the allantoic fluid of embryonated chicken eggs and its characteristics.
Tutykhina IL; Bezborodova OA; Shmarov MM; Logunov DY; Neugodova GL; Nemtsova ER; Naroditsky BS; Yakubovskaya RI; Gintsburg AL
Protein Expr Purif; 2009 May; 65(1):100-7. PubMed ID: 19174190
[TBL] [Abstract][Full Text] [Related]
53. [Efficacy of iron saturated recombinant human lactoferrin on alleviating iron deficiency anemia in rats].
Fang YH; Feng X; Xu H; Wu ZH; Xu YJ
Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Jun; 45(3):417-21. PubMed ID: 23774920
[TBL] [Abstract][Full Text] [Related]
54. 28-Day repeated dose oral toxicity of recombinant human apo-lactoferrin or recombinant human lysozyme in rats.
Cerven D; DeGeorge G; Bethell D
Regul Toxicol Pharmacol; 2008 Jul; 51(2):162-7. PubMed ID: 18457910
[TBL] [Abstract][Full Text] [Related]
55. Development and characterization of lactoferrin loaded poly(epsilon-caprolactone) nanofibers.
James EN; Nair LS
J Biomed Nanotechnol; 2014 Mar; 10(3):500-7. PubMed ID: 24730245
[TBL] [Abstract][Full Text] [Related]
56. Development of dairy herd of transgenic goats as biofactory for large-scale production of biologically active recombinant human lactoferrin.
Semak I; Budzevich A; Maliushkova E; Kuzniatsova V; Popkov N; Zalutsky I; Ivashkevich O
Transgenic Res; 2019 Dec; 28(5-6):465-478. PubMed ID: 31396786
[TBL] [Abstract][Full Text] [Related]
57. New insights into the systemic effects of oral lactoferrin: transcriptome profiling.
Kruzel ML; Olszewska P; Pazdrak B; Krupinska AM; Actor JK
Biochem Cell Biol; 2021 Feb; 99(1):47-53. PubMed ID: 32476452
[TBL] [Abstract][Full Text] [Related]
58. Recombinant human lactoferrin prevents NSAID-induced intestinal bleeding in rodents.
Dial EJ; Dohrman AJ; Romero JJ; Lichtenberger LM
J Pharm Pharmacol; 2005 Jan; 57(1):93-9. PubMed ID: 15651117
[TBL] [Abstract][Full Text] [Related]
59. Recombinant human lactoferrin and iron transport across Caco-2 monolayers: effect of heat treatment on the binding to cells.
Conesa C; Pocoví C; Pérez MD; Calvo M; Sánchez L
J Agric Food Chem; 2008 Apr; 56(8):2831-7. PubMed ID: 18355020
[TBL] [Abstract][Full Text] [Related]
60. Adipose-derived stem cells decrease pain in a rat model of oxaliplatin-induced neuropathy: Role of VEGF-A modulation.
Di Cesare Mannelli L; Tenci B; Micheli L; Vona A; Corti F; Zanardelli M; Lapucci A; Clemente AM; Failli P; Ghelardini C
Neuropharmacology; 2018 Mar; 131():166-175. PubMed ID: 29241656
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
